SCHEMBL5772284

SCHEMBL5772284

CS(=O)(=O)c1ccc(-c2csc(-c3n[nH]c4ccccc34)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
MAPT P10636 4/20 0.46
NPC1 O15118 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
ATR Q13535 3/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
GAA P10253 2/20 0.43
PDPK1 O15530 1/20 0.43
TTK P33981 2/20 0.43
ALDH1A1 P00352 1/20 0.41
ALPL P05186 1/20 0.41
IDO1 P14902 1/20 0.41
MAPK10 P53779 1/20 0.41
PTGS2 P35354 1/20 0.41
MAP2K4 P45985 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5777148 0.84 KDM4E (0.63) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5772080 0.84 KDM4E (0.60) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5771544 0.82 CYP19A1 (0.51) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5767848 0.81 CYP19A1 (0.54) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5769397 0.80 MAP2K4 (0.67) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5773440 0.79 MAPK1 (0.53) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5770757 0.79 CDC25A (0.49) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5778728 0.78 MEN1 (0.47) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5873083 0.78 NPC1 (0.50) KDM4EMEN1KMT2AMAPTNPC1
SCHEMBL5768166 0.77 IDO1 (0.66) KDM4ENPC1RAB9AALDH1A1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664040-A1 GYRASE INHIBITORS PFIZER INC. (US) 2006-06-07 EP disclosed
US-6984652-B2 Gyrase inhibitors WARNER-LAMBERT COMPANY LLC (US) 2006-01-10 US disclosed
US-20050250823-A1 Gyrase inhibitors YAGER KRAIG 2005-11-10 US disclosed
WO-2005026162-A1 GYRASE INHIBITORS PFIZER INC. (US) 2005-03-24 WO disclosed
US-20050054697-A1 Gyrase inhibitors PFIZER INC. 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054697-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B KDM4E 2869/4885MEN1 3349/4885KMT2A 3223/4885
US-20050250823-A1 Gyrase inhibitors TOP1, TOP2A, TOP2B KDM4E 2869/4885MEN1 3349/4885KMT2A 3223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.